시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 의료용 폴리카보네이트 시장 보고서(2025년)
Medical Polycarbonate Global Market Report 2025
상품코드 : 1825807
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의료용 폴리카보네이트 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.2%로 18억 8,000만 달러로 성장할 것입니다. 예측 기간 동안의 성장은 새로운 의료 용도에 대한 R&D 투자 증가, 생체적합성 재료에 대한 선호도 증가, 심혈관질환의 증가, 수술 건수 증가, 신흥 경제국의 의료 인프라 확대에 기인합니다. 예측 기간의 주요 동향으로는 기술 발전, 전략적 제휴, 공장 확장, 맞춤형 의료기기에 적층 성형 채택, 차세대 웨어러블 의료기술에 폴리카보네이트 통합 등이 있습니다.

향후 5년간 6.2%의 성장률 전망은 지난번 전망치보다 0.7% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 일본과 벨기에에서 수입되는 수술기구용 고급 폴리카보네이트 수지와 정맥주입용 부품의 가격을 급등시켜 공급 부족과 제조 비용 상승을 초래하여 미국의 의료기기 제조에 지장을 초래할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

만성질환의 유병률 증가는 향후 몇 년 동안 의료용 폴리카보네이트 시장의 성장을 견인할 것으로 보입니다. 만성질환은 지속적인 치료가 필요하고 일상생활과 삶의 질을 제한할 수 있는 장기적인 상태를 특징으로 하며, 생활습관의 변화, 유전적 소인, 환경오염물질 및 독소 노출 등 다양한 요인에 의해 증가 추세에 있습니다. 의료용 폴리카보네이트는 만성질환의 치료, 진단, 모니터링에 필수적인 장치 및 기기에 적용되고 있습니다. 예를 들어, 2023년 1월 미국 국립생물공학정보센터(NCBI)가 발표한 보고서에 따르면, 2050년까지 50세 이상에서 1개 이상의 만성질환을 앓고 있는 인구가 2020년 7,152만 2,000명에서 1,426만 6,000명으로 99.5% 증가할 것으로 예측하고 있습니다. 따라서 만성질환의 확산은 의료용 폴리카보네이트 시장의 중요한 촉진요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Medical polycarbonate stands as a specialized form of polycarbonate material tailored and produced explicitly for medical purposes. Its application extends to the manufacturing of diverse medical devices and equipment, owing to its biocompatibility, capacity for sterilization, and resilience to repeated cleaning and sterilization cycles.

The primary grades within the medical polycarbonate market encompass lipid-resistant grade, high-temperature grade, and other classifications. Lipid-resistant grade polycarbonate, a subset of medical-grade polycarbonate, is meticulously engineered to endure exposure to lipid emulsions, frequently utilized in intravenous (IV) therapy. Various processing technologies, including extrusion, injection molding, blow molding, and others, are deployed across a range of applications such as fluid delivery and IV connection components, renal dialysis products, cardiovascular devices, surgical instruments, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The medical polycarbonate market research report is one of a series of new reports from The Business Research Company that provides medical polycarbonate market statistics, including medical polycarbonate industry global market size, regional shares, competitors with a medical polycarbonate market share, detailed medical polycarbonate market segments, market trends, and opportunities, and any further data you may need to thrive in the medical polycarbonate industry. This medical polycarbonate research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medical polycarbonate market size has grown strongly in recent years. It will grow from $1.4 billion in 2024 to $1.48 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increased demand for personal protective equipment, increased prevalence of chronic diseases, increasing demand for durable and lightweight materials, rise in the number of diseases, and stringent regulatory standards.

The medical polycarbonate market size is expected to see strong growth in the next few years. It will grow to $1.88 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising investments in research and development for novel medical applications, growing preference for biocompatible materials, increased number of cardiovascular diseases, increased number of surgeries, and expanding healthcare infrastructure in emerging economies. Major trends in the forecast period include technological advancements, strategic collaborations, factory expansion, adoption of additive manufacturing for customized medical devices, and integration of polycarbonate in next-generation wearable health technologies.

The forecast of 6.2% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. medical device production by inflating prices of high-grade polycarbonate resins for surgical instruments and IV components imported from Japan and Belgium, resulting in supply shortages and higher manufacturing expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is poised to drive the growth of the medical polycarbonate market in the coming years. Chronic diseases, characterized by long-lasting conditions requiring ongoing medical attention and potentially limiting daily activities or quality of life, are on the rise due to various factors such as lifestyle changes, genetic predisposition, and exposure to environmental pollutants and toxins. Medical polycarbonate finds application in devices and instruments crucial for the treatment, diagnosis, and monitoring of chronic illnesses. For instance, a report from the National Center for Biotechnology Information (NCBI) in January 2023 projected a 99.5% increase in the number of individuals aged 50 and above suffering from one or more chronic diseases by 2050, reaching 142.66 million from 71.522 million in 2020. Hence, the growing prevalence of chronic diseases is a significant driver for the medical polycarbonate market.

Key players in the medical polycarbonate market are focusing on the development of innovative products, such as ultra-durable material solutions tailored for the healthcare and life sciences sectors, to maintain a competitive edge. Ultra-durable material solutions refer to materials engineered to withstand harsh conditions and stresses without significant degradation or failure. For example, in February 2023, Covestro AG introduced Makrolon 3638 polycarbonate, an ultra-durable material renowned for its exceptional strength, chemical resistance, and biocompatibility. Designed for medical devices and equipment requiring prolonged use and sterilization, this innovative material offers high thermal stability for consistent performance in extreme conditions, reducing the need for frequent replacements and enhancing cost-efficiency and reliability in medical applications.

In November 2022, Celanese Corporation completed the acquisition of DuPont de Nemours Inc.'s mobility and materials business for $11 billion. This strategic move aims to bolster Celanese's capabilities in the high-performance materials sector, expanding its portfolio of engineering thermoplastics, elastomers, and specialty polymers. DuPont de Nemours Inc. is a leading manufacturer of chemicals and specialty materials, including medical polycarbonate.

Major companies operating in the medical polycarbonate market are Bayer AG, LG Chem Ltd., Saudi Basic Industries Corporation, Asahi Kasei Corporation, Covestro AG, Lotte Chemical Corporation, Evonik Industries AG, Royal DSM N.V., Celanese Corporation, Teijin Limited, Trinseo S.A., Kolon Industries Inc., Avient Corporation, Daicel Corporation, Tekni-Plex Inc., Plaskolite LLC, RTP Company, Mitsubishi Engineering-Plastics Corporation, Chi Mei Corporation, Polyplastics Co. Ltd.

North America was the largest region in the medical polycarbonate market in 2024. The regions covered in the medical polycarbonate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical polycarbonate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical polycarbonate market consists of sales of medical imaging equipment, surgical instruments, drug delivery devices, and ophthalmological devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Polycarbonate Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical polycarbonate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical polycarbonate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical polycarbonate market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Medical Polycarbonate Market Characteristics

3. Medical Polycarbonate Market Trends And Strategies

4. Medical Polycarbonate Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Medical Polycarbonate Growth Analysis And Strategic Analysis Framework

6. Medical Polycarbonate Market Segmentation

7. Medical Polycarbonate Market Regional And Country Analysis

8. Asia-Pacific Medical Polycarbonate Market

9. China Medical Polycarbonate Market

10. India Medical Polycarbonate Market

11. Japan Medical Polycarbonate Market

12. Australia Medical Polycarbonate Market

13. Indonesia Medical Polycarbonate Market

14. South Korea Medical Polycarbonate Market

15. Western Europe Medical Polycarbonate Market

16. UK Medical Polycarbonate Market

17. Germany Medical Polycarbonate Market

18. France Medical Polycarbonate Market

19. Italy Medical Polycarbonate Market

20. Spain Medical Polycarbonate Market

21. Eastern Europe Medical Polycarbonate Market

22. Russia Medical Polycarbonate Market

23. North America Medical Polycarbonate Market

24. USA Medical Polycarbonate Market

25. Canada Medical Polycarbonate Market

26. South America Medical Polycarbonate Market

27. Brazil Medical Polycarbonate Market

28. Middle East Medical Polycarbonate Market

29. Africa Medical Polycarbonate Market

30. Medical Polycarbonate Market Competitive Landscape And Company Profiles

31. Medical Polycarbonate Market Other Major And Innovative Companies

32. Global Medical Polycarbonate Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Polycarbonate Market

34. Recent Developments In The Medical Polycarbonate Market

35. Medical Polycarbonate Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기